Role of oxytocin in the contractilityof the male reproductive tract: implications for the treatment of benign prostatic hyperplasia
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Abschlussarbeit Buch |
| Sprache: | English |
| Veröffentlicht: |
Gießen
VVB Laufersweiler Verlag
2021
|
| Ausgabe: | 1. Auflage |
| Schriftenreihe: | Edition Scientifique
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | 143 Seiten Illustrationen, Diagramme 21 cm x 14.8 cm, 200 g |
| ISBN: | 9783835969919 3835969919 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV048191287 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 220502s2021 gw a||| m||| 00||| eng d | ||
| 015 | |a 22,N03 |2 dnb | ||
| 016 | 7 | |a 1249092485 |2 DE-101 | |
| 020 | |a 9783835969919 |c : EUR 36.80 (DE) (freier Preis), EUR 37.90 (AT) (freier Preis), CHF 48.00 (freier Preis) |9 978-3-8359-6991-9 | ||
| 020 | |a 3835969919 |9 3-8359-6991-9 | ||
| 024 | 3 | |a 9783835969919 | |
| 035 | |a (OCoLC)1286075561 | ||
| 035 | |a (DE-599)DNB1249092485 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 044 | |a gw |c XA-DE-HE | ||
| 049 | |a DE-188 | ||
| 084 | |8 1\p |a 630 |2 23sdnb | ||
| 100 | 1 | |a Stadler, Beatrix |e Verfasser |0 (DE-588)1246333538 |4 aut | |
| 245 | 1 | 0 | |a Role of oxytocin in the contractilityof the male reproductive tract |b implications for the treatment of benign prostatic hyperplasia |c submitted by Beatrix Stadler |
| 250 | |a 1. Auflage | ||
| 263 | |a 202110 | ||
| 264 | 1 | |a Gießen |b VVB Laufersweiler Verlag |c 2021 | |
| 300 | |a 143 Seiten |b Illustrationen, Diagramme |c 21 cm x 14.8 cm, 200 g | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Edition Scientifique | |
| 502 | |b Habilitationsschrift |c Justus-Liebig-Universität Gießen |d 2021 | ||
| 650 | 7 | |a oxytocin |2 cabt | |
| 650 | 7 | |a male mammals |2 cabt | |
| 650 | 7 | |a prostate |2 cabt | |
| 650 | 7 | |a benign prostatic hyperplasia |2 cabt | |
| 650 | 7 | |a smooth muscle |2 cabt | |
| 650 | 7 | |a muscle contraction |2 cabt | |
| 650 | 7 | |a immunhistochemistry |2 cabt | |
| 650 | 7 | |a rats |2 cabt | |
| 653 | |a Prostata | ||
| 653 | |a Urologie | ||
| 653 | |a Hyperplasie | ||
| 655 | 7 | |0 (DE-588)4113937-9 |a Hochschulschrift |2 gnd-content | |
| 710 | 2 | |a VVB LAUFERSWEILER Verlag |0 (DE-588)1065553803 |4 pbl | |
| 856 | 4 | 2 | |m DNB Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=033572430&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-033572430 | ||
| 883 | 1 | |8 1\p |a vlb |d 20220110 |q DE-101 |u https://d-nb.info/provenance/plan#vlb | |
Datensatz im Suchindex
| _version_ | 1804183948536840192 |
|---|---|
| adam_text | DECLARATION
............................................................................................................................................
1
ACKNOWLEDGEMENT
..................................................................................................................................
2
TABLE
OF
CONTENT
......................................................................................................................................
3
TABLE
OF
FIGURES
.......................................................................................................................................
7
ABBREVIATIONS
.........................................................................................................................................
9
ABSTRACT
....................................................................................................................................................
11
INTRODUCTION
.............................................................................................................................................
12
INITIATION
OF
SMOOTH
MUSCLE
CONTRACTION
THROUGH
DIFFERENT
PATHWAYS
.............................................
12
SMOOTH
MUSCLE
CONTRACTION
...............................................................................................................
13
THE
ADRENERGIC
PATHWAY
....................................................................................................................
16
GROSS
ANATOMY
OF
THE
MALE
REPRODUCTIVE
TRACT
................................................................................
17
GENERAL
DEVELOPMENT
OF
THE
MALE
REPRODUCTIVE
SYSTEM
..................................................................
18
THE
PROSTATE
........................................................................................................................................
19
THE
HUMAN
PROSTATE
-
DEVELOPMENT,
ANATOMY,
HISTOLOGY
AND
FUNCTION
.....................................
19
THE
RAT
PROSTATE
-
DEVELOPMENT,
ANATOMY,
HISTOLOGY
AND
FUNCTION
...........................................
21
THE
CANINE
PROSTATE
IN
COMPARISON
..............................................................................................
23
BENIGN
PROSTATIC
HYPERPLASIA
.............................................................................................................
24
BENIGN
PROSTATIC
HYPERPLASIA
-
ETIOLOGY
AND
PREVALENCE
.............................................................
24
THE
TWO
LINES
OF
BPH
THERAPY
.......................................................................................................
25
THE
EPIDIDYMIS
...................................................................................................................................
26
SPECIFITIES
OF
THE
HUMAN
EPIDIDYMIS
...........................................................................................
28
SPECIFITIES
OF
THE
RAT
EPIDIDYMIS
...................................................................................................
28
THE
EJACULATORY
PROCESS
.....................................................................................................................
29
EJACULATORY
DISORDERS
-
ASSOCIATION
TO
BENIGN
PROSTATIC
HYPERPLASIA
...........................................
29
OXYTOCIN
.............................................................................................................................................
30
OXYTOCIN
AND
ITS
PATHWAY
.............................................................................................................
30
OXYTOCIN
SYSTEMIC
AND
LOCAL
..........................................................................................................
33
THE
RELEVANCE
OF
POSSIBLE
CROSSTALK
BETWEEN
OXYTOCIN
AND
ARGININE
VASOPRESSIN
.....................
34
RECEPTOR
DISTRIBUTION
AND
CONSIDERATION
OF
COLOCALIZATION
.........................................................
34
TABLE
1:
EXPRESSION
OF
OT
AND
OTR
IN
MALE
REPRODUCTIVE
TISSUES
OF
DIFFERENT
SPECIES
..................
39
TABLE
2
:
OVERVIEW
OF
THE
EFFECT
OF
OT
ON
THE
MALE
REPRODUCTIVE
TRACT
..........................................
42
OXYTOCIN
RELATED
TO
EMISSION
AND
COPULATION
..............................................................................
43
THE
EFFECT
OF
OXYTOCIN
ON
THE
CONTRACTILITY
OF
THE
EPIDIDYMIS
................................................
43
OXYTOCIN
IN
THE
PROSTATE
..............................................................................................................
44
THE
EFFECT
OF
OXYTOCIN
ON
THE
CONTRACTILITY
OF
THE
PROSTATE
....................................................44
3
OXYTOCIN-AGONISTS
AND
-ANTAGONISTS
.............................................................................................44
AIM
OF
THIS
STUDY
......................................................................................................................................
49
MATERIALS
AND
METHODS
............................................................................................................................
50
MATERIALS
.............................................................................................................................................
50
TISSUES
............................................................................................................................................
50
DEVICES
...........................................................................................................................................
51
SOFTWARE
.........................................................................................................................................
52
CONSUMABLES..................................................................................................................................
53
REAGENTS
AND
SUBSTANCES
.............................................................................................................
53
ACTIVE
AGENTS
.................................................................................................................................
56
ANTIBODIES
......................................................................................................................................
56
METHODS
..............................................................................................................................................
57
BUFFERS
AND
UTILITY
SOLUTIONS
..........................................................................................................
57
PREPARATION
OF
RAT
COLLAGEN
UTILITY
SOLUTION
...................................................................................
59
PREPARATION
OF
THE
DIFFERENT
TISSUES
FOR
LIVE
IMAGING
...................................................................
60
HUMAN
PROSTATE
.......................................................................................................................
60
RAT
PROSTATE
..............................................................................................................................
60
HUMAN
EPIDIDYMIS
...................................................................................................................
61
RAT
EPIDIDYMIS
..........................................................................................................................
62
LIVE
IMAGING
...................................................................................................................................
64
EXPERIMENTS
WITH
THE
RAT
OR
HUMAN
PROSTATE
.........................................................................
64
EXPERIMENTS
WITH
THE
NEONATAL
RAT
EPIDIDYMIS
......................................................................
64
EXPERIMENTS
WITH
THE
ADULT
RAT
OR
HUMAN
EPIDIDYMIS
............................................................
65
EXPERIMENTS
USING
DIFFERENT
SEGMENTS
OF
THE
RAT
OR
HUMAN
EPIDIDYMIS
.........................
65
EXPERIMENTS
WITH
S19
USING
THREE
DIFFERENT
CONCENTRATIONS
OF
OXYTOCIN
.........................
65
EXPERIMENTS
WITH
OXYTOCIN
AND
ARGININE
VASOPRESSIN-ANTAGONISTS
..................................
65
EXPERIMENTS
WITH
PHARMACOLOGICAL
IMPAIRMENT
OF
THE
ADRENERGIC
PATHWAY
..................
66
INJECTION
EXPERIMENTS
WITH
FRESH
FROZEN
(AND
THAWED
AGAIN)
HUMAN
PROSTATE
.........................
66
MICROINJECTION
OF
THE
HUMAN
PROSTATE
USING
TECHNOVIT*
3040
..............................................
67
MICROINJECTION
OF
HUMAN
PROSTATE
USING
MICROFIL*
MV-SERIES
............................................
68
USING
PROSTATES
FROM
HUMAN
BODY
DONORS
FOR
MICRO-CT
IMAGING
...............................................
68
(IMMUNO-)
HISTOCHEMISTRY
............................................................................................................
69
FIXATION
AND
SLICING
..................................................................................................................
69
HEIDENHAIN S
AZAN
TRICHROME
STAINING
...................................................................................
70
IMMUNOHISTOCHEMISTRY
.........................................................................................................
..70
CHROMOGENIC
IMMUNOHISTOCHEMISTRY
...............................................................................
70
IMMUNOFLUORESCENCE
..........................................................................................................
72
IMAGE
CAPTURE
OF
SLIDES.................................................................................................................
72
4
LIVE
IMAGING
ANALYSIS
.....................................................................................................................
72
STATISTICAL
ANALYSIS
.........................................................................................................................
73
RESULTS
......................................................................................................................................................
75
LIVE
IMAGING
.......................................................................................................................................
75
THE
EFFECT
OF
OXYTOCIN
ON
THE
CONTRACTILITY
OF
THE
PROSTATE
.........................................................
75
THE
EFFECT
OF
OXYTOCIN
ON
THE
CONTRACTILITY
OF
THE
HUMAN
PROSTATE
........................................
75
THE
EFFECT
OF
OXYTOCIN
ON
THE
CONTRACTILITY
OF
THE
RAT
PROSTATE
(GLANDS)................................
77
THE
EFFECT
OF
OXYTOCIN
ON
THE
CONTRACTILITY
OF
THE
EPIDIDYMIS
.....................................................
78
THE
DIFFERENCE
OF
EFFECT
OF
OXYTOCIN
ON
THE
CONTRACTILITY
OF
SPECIFIC
SEGMENTS
OF
THE
ADULT
RAT
EPIDIDYMIS
..............................................................................................................................
78
THE
DIFFERENCE
OF
EFFECT
OF
OXYTOCIN
ON
THE
CONTRACTILITY
OF
SPECIFIC
SEGMENTS
OF
THE
NEONATAL
RAT
EPIDIDYMIS
.........................................................................................................................
82
THE
EFFECT
OF
OXYTOCIN
ON
THE
CONTRACTILITY
OF
THE
HUMAN
EPIDIDYMIS
...................................
83
THE
EFFECT
OF
DIFFERENT
CONCENTRATIONS
OF
OXYTOCIN
ON
THE
CONTRACTILITY
OF
S19
OF
THE
ADULT
RAT
EPIDIDYMIS
...............................................................................................................................
84
BLOCKING
OXYTOCIN
IN
S19
OF
THE
ADULT
RAT
EPIDIDYMIS
.............................................................
86
ADDITION
OF
OXYTOCIN
TO
ADRENERGICALLY
BLOCKED
S19
OF
THE
ADULT
RAT
AND
S9
OF
THE
HUMAN
EPIDIDYMIS
...................................
89
DISTRIBUTION
OF
THE
OXYTOCIN
RECEPTOR
................................................................................................
91
HUMAN
PROSTATE
............................................................................................................................
91
RAT
PROSTATE
..................................................................................................................................
94
RAT
EPIDIDYMIS
..............................................................................................................................
96
FINE
STRUCTURE
OF
THE
HUMAN
PROSTATIC
DUCTAL
SYSTEM
.......................................................................
98
TECHNOVIT
INJECTION
......................................................................................................................
98
MICROFIL*
INJECTION
AND
RECONSTRUCTION
.....................................................................................
99
MICRO-CT
IMAGING
OF
HUMAN
PROSTATE
.........................................................................................
100
MICRO-CT
IMAGING
OF
HUMAN
PROSTATE
AND
CORRESPONDING
HISTOLOGY
..........................................
102
SMA
ORIENTATION
HUMAN
PROSTATIC
GLAND
VS
DUCT
.......................................................................
104
DISCUSSION
..............................................................................................................................................
105
A
NEW
ANALYZING
METHOD
FOR
LIVE
IMAGING
DATA
...............................................................................
105
THE
EFFECT
OF
OXYTOCIN
IN
THE
PROSTATE
............................................................................................
107
THE
EFFECT
OF
OXYTOCIN
IN
THE
EPIDIDYMIS
........................................................................................
110
OXYTOCIN
AS
A
THERAPEUTIC
................................................................................................................
114
S19
AS
A
MODEL
.................................................................................................................................
116
THE
HUMAN
PROSTATIC
DUCT
SYSTEM
...................................................................................................
117
SUMMARY
...............................................................................................................................................
119
ZUSAMMENFASSUNG
................................................................................................................................
121
REFERENCES
............................................................................................................................................
123
PUBLICATIONS,
TALKS,
POSTERS
AND
PRIZES/GRANTS
.....................................................................................
138
5
PUBLICATIONS
IN
PEER-REVIEWED
JOURNALS
...........................................................................................
137
TALKS
..................................................................................................................................................
138
POSTERS
..............................................................................................................................................
138
PRIZES/GRANTS
.....................................................................................................................................
140
6
|
| adam_txt |
DECLARATION
.
1
ACKNOWLEDGEMENT
.
2
TABLE
OF
CONTENT
.
3
TABLE
OF
FIGURES
.
7
ABBREVIATIONS
.
9
ABSTRACT
.
11
INTRODUCTION
.
12
INITIATION
OF
SMOOTH
MUSCLE
CONTRACTION
THROUGH
DIFFERENT
PATHWAYS
.
12
SMOOTH
MUSCLE
CONTRACTION
.
13
THE
ADRENERGIC
PATHWAY
.
16
GROSS
ANATOMY
OF
THE
MALE
REPRODUCTIVE
TRACT
.
17
GENERAL
DEVELOPMENT
OF
THE
MALE
REPRODUCTIVE
SYSTEM
.
18
THE
PROSTATE
.
19
THE
HUMAN
PROSTATE
-
DEVELOPMENT,
ANATOMY,
HISTOLOGY
AND
FUNCTION
.
19
THE
RAT
PROSTATE
-
DEVELOPMENT,
ANATOMY,
HISTOLOGY
AND
FUNCTION
.
21
THE
CANINE
PROSTATE
IN
COMPARISON
.
23
BENIGN
PROSTATIC
HYPERPLASIA
.
24
BENIGN
PROSTATIC
HYPERPLASIA
-
ETIOLOGY
AND
PREVALENCE
.
24
THE
TWO
LINES
OF
BPH
THERAPY
.
25
THE
EPIDIDYMIS
.
26
SPECIFITIES
OF
THE
HUMAN
EPIDIDYMIS
.
28
SPECIFITIES
OF
THE
RAT
EPIDIDYMIS
.
28
THE
EJACULATORY
PROCESS
.
29
EJACULATORY
DISORDERS
-
ASSOCIATION
TO
BENIGN
PROSTATIC
HYPERPLASIA
.
29
OXYTOCIN
.
30
OXYTOCIN
AND
ITS
PATHWAY
.
30
OXYTOCIN
SYSTEMIC
AND
LOCAL
.
33
THE
RELEVANCE
OF
POSSIBLE
CROSSTALK
BETWEEN
OXYTOCIN
AND
ARGININE
VASOPRESSIN
.
34
RECEPTOR
DISTRIBUTION
AND
CONSIDERATION
OF
COLOCALIZATION
.
34
TABLE
1:
EXPRESSION
OF
OT
AND
OTR
IN
MALE
REPRODUCTIVE
TISSUES
OF
DIFFERENT
SPECIES
.
39
TABLE
2
:
OVERVIEW
OF
THE
EFFECT
OF
OT
ON
THE
MALE
REPRODUCTIVE
TRACT
.
42
OXYTOCIN
RELATED
TO
EMISSION
AND
COPULATION
.
43
THE
EFFECT
OF
OXYTOCIN
ON
THE
CONTRACTILITY
OF
THE
EPIDIDYMIS
.
43
OXYTOCIN
IN
THE
PROSTATE
.
44
THE
EFFECT
OF
OXYTOCIN
ON
THE
CONTRACTILITY
OF
THE
PROSTATE
.44
3
OXYTOCIN-AGONISTS
AND
-ANTAGONISTS
.44
AIM
OF
THIS
STUDY
.
49
MATERIALS
AND
METHODS
.
50
MATERIALS
.
50
TISSUES
.
50
DEVICES
.
51
SOFTWARE
.
52
CONSUMABLES.
53
REAGENTS
AND
SUBSTANCES
.
53
ACTIVE
AGENTS
.
56
ANTIBODIES
.
56
METHODS
.
57
BUFFERS
AND
UTILITY
SOLUTIONS
.
57
PREPARATION
OF
RAT
COLLAGEN
UTILITY
SOLUTION
.
59
PREPARATION
OF
THE
DIFFERENT
TISSUES
FOR
LIVE
IMAGING
.
60
HUMAN
PROSTATE
.
60
RAT
PROSTATE
.
60
HUMAN
EPIDIDYMIS
.
61
RAT
EPIDIDYMIS
.
62
LIVE
IMAGING
.
64
EXPERIMENTS
WITH
THE
RAT
OR
HUMAN
PROSTATE
.
64
EXPERIMENTS
WITH
THE
NEONATAL
RAT
EPIDIDYMIS
.
64
EXPERIMENTS
WITH
THE
ADULT
RAT
OR
HUMAN
EPIDIDYMIS
.
65
EXPERIMENTS
USING
DIFFERENT
SEGMENTS
OF
THE
RAT
OR
HUMAN
EPIDIDYMIS
.
65
EXPERIMENTS
WITH
S19
USING
THREE
DIFFERENT
CONCENTRATIONS
OF
OXYTOCIN
.
65
EXPERIMENTS
WITH
OXYTOCIN
AND
ARGININE
VASOPRESSIN-ANTAGONISTS
.
65
EXPERIMENTS
WITH
PHARMACOLOGICAL
IMPAIRMENT
OF
THE
ADRENERGIC
PATHWAY
.
66
INJECTION
EXPERIMENTS
WITH
FRESH
FROZEN
(AND
THAWED
AGAIN)
HUMAN
PROSTATE
.
66
MICROINJECTION
OF
THE
HUMAN
PROSTATE
USING
TECHNOVIT*
3040
.
67
MICROINJECTION
OF
HUMAN
PROSTATE
USING
MICROFIL*
MV-SERIES
.
68
USING
PROSTATES
FROM
HUMAN
BODY
DONORS
FOR
MICRO-CT
IMAGING
.
68
(IMMUNO-)
HISTOCHEMISTRY
.
69
FIXATION
AND
SLICING
.
69
HEIDENHAIN'S
AZAN
TRICHROME
STAINING
.
70
IMMUNOHISTOCHEMISTRY
.
.70
CHROMOGENIC
IMMUNOHISTOCHEMISTRY
.
70
IMMUNOFLUORESCENCE
.
72
IMAGE
CAPTURE
OF
SLIDES.
72
4
LIVE
IMAGING
ANALYSIS
.
72
STATISTICAL
ANALYSIS
.
73
RESULTS
.
75
LIVE
IMAGING
.
75
THE
EFFECT
OF
OXYTOCIN
ON
THE
CONTRACTILITY
OF
THE
PROSTATE
.
75
THE
EFFECT
OF
OXYTOCIN
ON
THE
CONTRACTILITY
OF
THE
HUMAN
PROSTATE
.
75
THE
EFFECT
OF
OXYTOCIN
ON
THE
CONTRACTILITY
OF
THE
RAT
PROSTATE
(GLANDS).
77
THE
EFFECT
OF
OXYTOCIN
ON
THE
CONTRACTILITY
OF
THE
EPIDIDYMIS
.
78
THE
DIFFERENCE
OF
EFFECT
OF
OXYTOCIN
ON
THE
CONTRACTILITY
OF
SPECIFIC
SEGMENTS
OF
THE
ADULT
RAT
EPIDIDYMIS
.
78
THE
DIFFERENCE
OF
EFFECT
OF
OXYTOCIN
ON
THE
CONTRACTILITY
OF
SPECIFIC
SEGMENTS
OF
THE
NEONATAL
RAT
EPIDIDYMIS
.
82
THE
EFFECT
OF
OXYTOCIN
ON
THE
CONTRACTILITY
OF
THE
HUMAN
EPIDIDYMIS
.
83
THE
EFFECT
OF
DIFFERENT
CONCENTRATIONS
OF
OXYTOCIN
ON
THE
CONTRACTILITY
OF
S19
OF
THE
ADULT
RAT
EPIDIDYMIS
.
84
BLOCKING
OXYTOCIN
IN
S19
OF
THE
ADULT
RAT
EPIDIDYMIS
.
86
ADDITION
OF
OXYTOCIN
TO
ADRENERGICALLY
BLOCKED
S19
OF
THE
ADULT
RAT
AND
S9
OF
THE
HUMAN
EPIDIDYMIS
.
89
DISTRIBUTION
OF
THE
OXYTOCIN
RECEPTOR
.
91
HUMAN
PROSTATE
.
91
RAT
PROSTATE
.
94
RAT
EPIDIDYMIS
.
96
FINE
STRUCTURE
OF
THE
HUMAN
PROSTATIC
DUCTAL
SYSTEM
.
98
TECHNOVIT
'
INJECTION
.
98
MICROFIL*
INJECTION
AND
RECONSTRUCTION
.
99
MICRO-CT
IMAGING
OF
HUMAN
PROSTATE
.
100
MICRO-CT
IMAGING
OF
HUMAN
PROSTATE
AND
CORRESPONDING
HISTOLOGY
.
102
SMA
ORIENTATION
HUMAN
PROSTATIC
GLAND
VS
DUCT
.
104
DISCUSSION
.
105
A
NEW
ANALYZING
METHOD
FOR
LIVE
IMAGING
DATA
.
105
THE
EFFECT
OF
OXYTOCIN
IN
THE
PROSTATE
.
107
THE
EFFECT
OF
OXYTOCIN
IN
THE
EPIDIDYMIS
.
110
OXYTOCIN
AS
A
THERAPEUTIC
.
114
S19
AS
A
MODEL
.
116
THE
HUMAN
PROSTATIC
DUCT
SYSTEM
.
117
SUMMARY
.
119
ZUSAMMENFASSUNG
.
121
REFERENCES
.
123
PUBLICATIONS,
TALKS,
POSTERS
AND
PRIZES/GRANTS
.
138
5
PUBLICATIONS
IN
PEER-REVIEWED
JOURNALS
.
137
TALKS
.
138
POSTERS
.
138
PRIZES/GRANTS
.
140
6 |
| any_adam_object | 1 |
| any_adam_object_boolean | 1 |
| author | Stadler, Beatrix |
| author_GND | (DE-588)1246333538 |
| author_facet | Stadler, Beatrix |
| author_role | aut |
| author_sort | Stadler, Beatrix |
| author_variant | b s bs |
| building | Verbundindex |
| bvnumber | BV048191287 |
| ctrlnum | (OCoLC)1286075561 (DE-599)DNB1249092485 |
| edition | 1. Auflage |
| format | Thesis Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02170nam a2200553 c 4500</leader><controlfield tag="001">BV048191287</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">220502s2021 gw a||| m||| 00||| eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">22,N03</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1249092485</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783835969919</subfield><subfield code="c">: EUR 36.80 (DE) (freier Preis), EUR 37.90 (AT) (freier Preis), CHF 48.00 (freier Preis)</subfield><subfield code="9">978-3-8359-6991-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3835969919</subfield><subfield code="9">3-8359-6991-9</subfield></datafield><datafield tag="024" ind1="3" ind2=" "><subfield code="a">9783835969919</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1286075561</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1249092485</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-HE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-188</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="8">1\p</subfield><subfield code="a">630</subfield><subfield code="2">23sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Stadler, Beatrix</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1246333538</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Role of oxytocin in the contractilityof the male reproductive tract</subfield><subfield code="b">implications for the treatment of benign prostatic hyperplasia</subfield><subfield code="c">submitted by Beatrix Stadler</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1. Auflage</subfield></datafield><datafield tag="263" ind1=" " ind2=" "><subfield code="a">202110</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Gießen</subfield><subfield code="b">VVB Laufersweiler Verlag</subfield><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">143 Seiten</subfield><subfield code="b">Illustrationen, Diagramme</subfield><subfield code="c">21 cm x 14.8 cm, 200 g</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Edition Scientifique</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="b">Habilitationsschrift</subfield><subfield code="c">Justus-Liebig-Universität Gießen</subfield><subfield code="d">2021</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">oxytocin</subfield><subfield code="2">cabt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">male mammals</subfield><subfield code="2">cabt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">prostate</subfield><subfield code="2">cabt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">benign prostatic hyperplasia</subfield><subfield code="2">cabt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">smooth muscle</subfield><subfield code="2">cabt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">muscle contraction</subfield><subfield code="2">cabt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">immunhistochemistry</subfield><subfield code="2">cabt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">rats</subfield><subfield code="2">cabt</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Prostata</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Urologie</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Hyperplasie</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">VVB LAUFERSWEILER Verlag</subfield><subfield code="0">(DE-588)1065553803</subfield><subfield code="4">pbl</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">DNB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=033572430&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-033572430</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">vlb</subfield><subfield code="d">20220110</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#vlb</subfield></datafield></record></collection> |
| genre | (DE-588)4113937-9 Hochschulschrift gnd-content |
| genre_facet | Hochschulschrift |
| id | DE-604.BV048191287 |
| illustrated | Illustrated |
| index_date | 2024-07-03T19:44:43Z |
| indexdate | 2024-07-10T09:31:33Z |
| institution | BVB |
| institution_GND | (DE-588)1065553803 |
| isbn | 9783835969919 3835969919 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-033572430 |
| oclc_num | 1286075561 |
| open_access_boolean | |
| owner | DE-188 |
| owner_facet | DE-188 |
| physical | 143 Seiten Illustrationen, Diagramme 21 cm x 14.8 cm, 200 g |
| publishDate | 2021 |
| publishDateSearch | 2021 |
| publishDateSort | 2021 |
| publisher | VVB Laufersweiler Verlag |
| record_format | marc |
| series2 | Edition Scientifique |
| spelling | Stadler, Beatrix Verfasser (DE-588)1246333538 aut Role of oxytocin in the contractilityof the male reproductive tract implications for the treatment of benign prostatic hyperplasia submitted by Beatrix Stadler 1. Auflage 202110 Gießen VVB Laufersweiler Verlag 2021 143 Seiten Illustrationen, Diagramme 21 cm x 14.8 cm, 200 g txt rdacontent n rdamedia nc rdacarrier Edition Scientifique Habilitationsschrift Justus-Liebig-Universität Gießen 2021 oxytocin cabt male mammals cabt prostate cabt benign prostatic hyperplasia cabt smooth muscle cabt muscle contraction cabt immunhistochemistry cabt rats cabt Prostata Urologie Hyperplasie (DE-588)4113937-9 Hochschulschrift gnd-content VVB LAUFERSWEILER Verlag (DE-588)1065553803 pbl DNB Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=033572430&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis 1\p vlb 20220110 DE-101 https://d-nb.info/provenance/plan#vlb |
| spellingShingle | Stadler, Beatrix Role of oxytocin in the contractilityof the male reproductive tract implications for the treatment of benign prostatic hyperplasia oxytocin cabt male mammals cabt prostate cabt benign prostatic hyperplasia cabt smooth muscle cabt muscle contraction cabt immunhistochemistry cabt rats cabt |
| subject_GND | (DE-588)4113937-9 |
| title | Role of oxytocin in the contractilityof the male reproductive tract implications for the treatment of benign prostatic hyperplasia |
| title_auth | Role of oxytocin in the contractilityof the male reproductive tract implications for the treatment of benign prostatic hyperplasia |
| title_exact_search | Role of oxytocin in the contractilityof the male reproductive tract implications for the treatment of benign prostatic hyperplasia |
| title_exact_search_txtP | Role of oxytocin in the contractilityof the male reproductive tract implications for the treatment of benign prostatic hyperplasia |
| title_full | Role of oxytocin in the contractilityof the male reproductive tract implications for the treatment of benign prostatic hyperplasia submitted by Beatrix Stadler |
| title_fullStr | Role of oxytocin in the contractilityof the male reproductive tract implications for the treatment of benign prostatic hyperplasia submitted by Beatrix Stadler |
| title_full_unstemmed | Role of oxytocin in the contractilityof the male reproductive tract implications for the treatment of benign prostatic hyperplasia submitted by Beatrix Stadler |
| title_short | Role of oxytocin in the contractilityof the male reproductive tract |
| title_sort | role of oxytocin in the contractilityof the male reproductive tract implications for the treatment of benign prostatic hyperplasia |
| title_sub | implications for the treatment of benign prostatic hyperplasia |
| topic | oxytocin cabt male mammals cabt prostate cabt benign prostatic hyperplasia cabt smooth muscle cabt muscle contraction cabt immunhistochemistry cabt rats cabt |
| topic_facet | oxytocin male mammals prostate benign prostatic hyperplasia smooth muscle muscle contraction immunhistochemistry rats Hochschulschrift |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=033572430&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT stadlerbeatrix roleofoxytocininthecontractilityofthemalereproductivetractimplicationsforthetreatmentofbenignprostatichyperplasia AT vvblaufersweilerverlag roleofoxytocininthecontractilityofthemalereproductivetractimplicationsforthetreatmentofbenignprostatichyperplasia |